Skip to main content
Clinical Trials/CTRI/2022/07/044123
CTRI/2022/07/044123
Not yet recruiting
未知

A Synopsis on Effectiveness of Individualized Homoeopathic medicines and Chimaphila umbellata Mother tincture in the treatment of Benign Prostatic Hyperplasia: An Open Randomized Clinical Trial

ational Institute Of Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N40- Benign prostatic hyperplasia
Sponsor
ational Institute Of Homoeopathy
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute Of Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • a)Patients presenting symptoms of Benign Prostatic Hyperplasia with or without evidence of bladder outflow obstruction (AUASS more than 7\) b)Patients suffering from cases of Benign Prostatic Hyperplasia diagnosed radiologically (USG\-PELVIS) and ultrasonographical examination of Prostate weight more than 20g/20cc and RUV of more than 30ml c)Patients already undergoing regular therapy for BPH, provided the medications are stopped completely at least 2weeks prior study entry d)Male patients of all religions and of different socioeconomic status e)Patients with known but controlled systemic diseases f)Patients giving written consent to participate in the study

Exclusion Criteria

  • a)Patients with Serum Prostate specific antigen (PSA) more than 4 nmol/mL to rule out suspected
  • prostatic malignancy
  • b)Cases suffering from uncontrolled systemic illness or life\-threatening conditions.
  • c)Patient suffering from complete retention of urine for more than 24hrs.
  • d)Patient with frequent urination or retention of urine due to systemic or neurological disorder.
  • e)Patient suffering from neurogenic bladder or urethral stricture

Outcomes

Primary Outcomes

Not specified

Similar Trials